Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neuropace Inc
(NQ:
NPCE
)
6.870
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Neuropace Inc
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
April 17, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
March 05, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
December 01, 2023
RNS System featured in over 50 Scientific Presentations and Posters
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 06, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
October 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Participate in Upcoming Investor Conferences
August 24, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 08, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces CEO Transition
June 28, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
May 24, 2023
To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace’s RNS System
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
April 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 03, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
March 02, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 10, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
January 09, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
November 30, 2022
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 08, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
November 04, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022
October 25, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)
October 11, 2022
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents
May 04, 2022
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Information About Their Patients’ Seizure Burden
August 04, 2021
From
NeuroPace
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.